CDX-301 Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Converting HR+ Breast Cancer Into an Individualized Vaccine
Breast Cancer
Weill Medical College of Cornell University100 enrolled8 locationsNCT03804944
Recruiting
Phase 1
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Metastatic Breast CancerHER2-negative Breast Cancer
University of Texas Southwestern Medical Center30 enrolled7 locationsNCT05029999
Recruiting
Phase 1
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
MelanomaMetastatic Melanoma
Dana-Farber Cancer Institute30 enrolled1 locationNCT04930783